Juan L. Mendoza

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Structural biology, protein engineering, immunology, drug design
Google:
"Juan Mendoza"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mendoza JL, Fischer S, Gee MH, et al. (2020) Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity. Elife. 9
Mendoza JL, Fischer S, Gee MH, et al. (2020) Author response: Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity Elife
Mendoza JL, Escalante NK, Jude KM, et al. (2019) Structure of the IFNγ receptor complex guides design of biased agonists. Nature
Pervolaraki K, Rastgou Talemi S, Albrecht D, et al. (2018) Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. Plos Pathogens. 14: e1007420
Illing PT, Pymm P, Croft NP, et al. (2018) HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nature Communications. 9: 4693
Bamford CGG, Aranday-Cortes E, Filipe IC, et al. (2018) A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages. Plos Pathogens. 14: e1007307
Riley TP, Hellman LM, Gee MH, et al. (2018) T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability. Nature Chemical Biology. 14: 934-942
Gee MH, Sibener LV, Birnbaum ME, et al. (2018) Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro. Proceedings of the National Academy of Sciences of the United States of America
Gee MH, Han A, Lofgren SM, et al. (2017) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell
Hilton HG, McMurtrey CP, Han AS, et al. (2017) The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Reports. 19: 1394-1405
See more...